Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreas Adenocarcinomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT07219238
What this trial is testing

Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)

Who this might be right for
Colorectal CancerGastric CancersOvarian Cancers+1 more
GE Healthcare 175
Not applicableLooking for participantsNCT06287749
What this trial is testing

French Assessment of MRD by Liquid Biopsies in PDAC Patients (FRENCH.MRD.PDAC)

Who this might be right for
Pancreatic Cancer ResectablePancreatic Ductal AdenocarcinomaMinimal Residual Disease+2 more
University Hospital, Montpellier 37
Testing effectiveness (Phase 2)Study completedNCT00154791
What this trial is testing

Phase I/II Trial GOFL in Advanced Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Adenocarcinoma
National Taiwan University Hospital 45
Testing effectiveness (Phase 2)Study completedNCT00005926
What this trial is testing

Gemcitabine, Herceptin and Radiation to Treat Cancer of the Pancreas

Who this might be right for
Pancreatic CancerPancreatic Neoplasm
National Cancer Institute (NCI) 50
Early research (Phase 1)UnknownNCT05088889
What this trial is testing

Maintenance Ipilimumab + Nivolumab Post Induction Chemotherapy + SBRT for First Line Treatment Stage IV Pancreatic Cancer

Who this might be right for
Stage IV Pancreatic Cancer
Sheba Medical Center 10
Testing effectiveness (Phase 2)Ended earlyNCT03469258
What this trial is testing

Study of Pancreatic Enzyme Replacement on Completion of Adjuvant Chemotherapy for Resected Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Cancer
Dana-Farber Cancer Institute 4
Not applicableLooking for participantsNCT07542041
What this trial is testing

Artidis Nanomechanical Signature Profiling of Pancreatic Cancer Specimens

Who this might be right for
Pancreatic CancerPancreatic NeoplasmsPancreatic Ductal Adenocarcinoma (PDAC)+1 more
ARTIDIS AG 200
Early research (Phase 1)Ended earlyNCT01233505
What this trial is testing

Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors

Who this might be right for
Adenocarcinoma of the PancreasAdenocarcinoma of the StomachBRCA1 Mutation Carrier+23 more
National Cancer Institute (NCI) 16
Early research (Phase 1)Study completedNCT00475956
What this trial is testing

Safety and Tolerability Study of AZD2171 in Combination With AZD0530 in Patients With Advanced Solid Tumours

Who this might be right for
Neoplasms
AstraZeneca 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT07176702
What this trial is testing

A Phase II Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy

Who this might be right for
Metastatic PDACHER2-positive Status
Shanghai Zhongshan Hospital 45
Early research (Phase 1)Ended earlyNCT00415454
What this trial is testing

Study Combining Suicide Gene Therapy With Chemoradiotherapy in the Treatment of Non-Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Cancer
Henry Ford Health System 8
Early research (Phase 1)Active Not RecruitingNCT05156866
What this trial is testing

First in Human Study of TORL-2-307-ADC in Participants With Advanced Cancer

Who this might be right for
Advanced Solid TumorGastric CancerPancreas Cancer+1 more
TORL Biotherapeutics, LLC 163
Not applicableWithdrawnNCT02872831
What this trial is testing

Beacon BNX™ Endoscopic Ultrasound (EUS)-Needle vs SharkCore™ Needle

Who this might be right for
Pancreatic CancerLymphadenopathyCholangiocarcinoma
Thomas Jefferson University
Not applicableActive Not RecruitingNCT02921022
What this trial is testing

Study Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic CancerAdvanced Pancreatic Ductal Adenocarcinoma
Memorial Sloan Kettering Cancer Center 110
Large-scale testing (Phase 3)Study completedNCT00099294
What this trial is testing

Study of the Efficacy and Safety of Glufosfamide Compared With Best Supportive Care in Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Threshold Pharmaceuticals 300
Testing effectiveness (Phase 2)UnknownNCT02839954
What this trial is testing

CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor

Who this might be right for
Hepatocellular CarcinomaNon-small Cell Lung CancerPancreatic Carcinoma+4 more
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10
Testing effectiveness (Phase 2)Study completedNCT03161379
What this trial is testing

GVAX Pancreas Vaccine (With CY) in Combination With Nivolumab and SBRT for Patients With Borderline Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 31
Testing effectiveness (Phase 2)Looking for participantsNCT07410494
What this trial is testing

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Who this might be right for
CancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more
Essen Biotech 85
Early research (Phase 1)Looking for participantsNCT06010862
What this trial is testing

Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors

Who this might be right for
Gastric CancerColon CancerPancreas Cancer+4 more
Chongqing Precision Biotech Co., Ltd 36
Early research (Phase 1)Active Not RecruitingNCT07118176
What this trial is testing

Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers

Who this might be right for
Anal CarcinomaBladder CarcinomaBreast Carcinoma+31 more
Jonsson Comprehensive Cancer Center 30
Next Page